READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRANSDERM-NITRO nitroglycerin patch

Similar documents
Nitro-Dur 0.2 mg/h, 0.4 mg/h, 0.6 mg/h Transdermal Patch Glyceryl trinitrate

PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

Transiderm-Nitro 5 milligrams/24 hours, Transiderm-Nitro10 milligrams/24 hours and Transiderm-Nitro15 milligrams/24 hours Transdermal patch

INFORMATION FOR THE CONSUMER

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection

Medication Guide Fentanyl transdermal system, CII Rx Only Fentanyl transdermal system is: A strong prescription pain medicine that contains an opioid

ONBREZ BREEZHALER should only be used to treat COPD.

PATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system)

Medication Guide Fentanyl Transdermal System, CII (fĕn tə-nĭl) Fentanyl transdermal system is:

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION. ixekizumab

Transiderm-Nitro 5 and 10 (glyceryl trinitrate)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION LIPIDIL EZ. fenofibrate, NanoCrystal formulation tablets

PATIENT MEDICATION INFORMATION RAVICTI TM. (glycerol phenylbutyrate) Oral Liquid

Patient Information. Sancuso [san-koo-so] (granisetron transdermal system)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. APO-SALVENT CFC FREE salbutamol sulphate inhalation aerosol

PATIENT MEDICATION INFORMATION. MEGACE OS Megestrol acetate Oral Suspension

OXEZE TURBUHALER formoterol fumarate dihydrate

PATIENT INFORMATION. C ardiac Diseases. Anti-anginal Agents (I) Nitrates

PACKAGE LEAFLET: INFORMATION FOR THE USER. Rectogesic 4 mg/g Rectal Ointment Glyceryl trinitrate

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. PRINIVIL (lisinopril tablets, Merck Standard)

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE

PRODUCT MONOGRAPH. Pr KYTRIL. granisetron hydrochloride tablets. 1 mg granisetron as hydrochloride. Manufacture Standard

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ERYC Erythromycin delayed release capsules USP

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Palbociclib Capsules

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Pentamidine Isetionate for Injection BP (pentamidine isetionate)

PATIENT INFORMATION NEUPRO [NU pro] (rotigotine transdermal system)

Steglatro ertugliflozin tablets

PART III: CONSUMER INFORMATION XOLAIR (omalizumab)

OXEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. rabeprazole sodium tablets

IMPORTANT: PLEASE READ

PART III: CONSUMER INFORMATION ABOUT THIS MEDICATION. APO-FENTANYL MATRIX fentanyl transdermal system

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (omeprazole delayed release capsules USP)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. AIM-oh-vig Pr AIMOVIG (erenumab injection)

IMPORTANT: PLEASE READ

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ZEPATIER 50 mg of elbasvir and 100 mg of grazoprevir

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ERLEADA apalutamide tablets

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Buscopan Hyoscine Butylbromide Injection

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (em-plis-city)

IMPORTANT: PLEASE READ

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. N FENTANYL PATCH Fentanyl Transdermal Patches (Matrix)

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ALECENSARO. alectinib (as alectinib hydrochloride) Capsule, 150 mg

IMPORTANT: PLEASE READ

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SABRIL (vigabatrin)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. PIFELTRO doravirine tablets

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. Pantoprazole Magnesium Enteric-Coated Tablets

Glatopa is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).

Patient Information. For patients with diabetes, if you are taking TWYNSTA you should not take aliskiren.

Tell your doctor if you have ever abused or been dependent on alcohol, prescription medicine or street drugs.

IMPORTANT: PLEASE READ

The capsule shell contains hypromellose, purified water, carrageenan, potassium chloride and FDC Yellow 6 (110 Sunset Yellow FCF).

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. PATIENT MEDICATION INFORMATION SPINRAZA nusinersen injection

IMPORTANT: PLEASE READ

PART III: CONSUMER INFORMATION WARNINGS AND PRECAUTIONS. ANDROGEL Testosterone gel 1%

KEEP IT SIMPLE WITH SANCUSO. Prevent chemotherapy induced nausea and vomiting with Sancuso Patch for up to 5 full days3

PART III: CONSUMER INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION ORILISSA. elagolix (as elagolix sodium) tablets

COMBIVENT UDV Product Monograph Page 35 of 39

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. DEPO-PROVERA Medroxyprogesterone acetate injectable suspension

PART III: CONSUMER INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

CONSUMER INFORMATION. Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

PRESCRIBING INFORMATION

MINITRAN 0.2 mg/hr MINITRAN 0.4 mg/hr MINITRAN 0.6 mg/hr

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (Pentazocine Lactate Injection, USP)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION 1. Esomeprazole Magnesium

PRODUCT MONOGRAPH. Pr PROLOPA. levodopa and benserazide capsules. 50 mg mg, 100 mg - 25 mg, 200 mg - 50mg. Pharmaceutical standard: professed

PATIENT INFORMATION LEAFLET CARZIN XL

READ THIS FOR SAFE AND EFECTIVE USE OF YOUR MEDICATION PATIENT MEDICATION INFORMATION. Lansoprazole delayed release capsules

IE/H/109/ /II/017 PACKAGE LEAFLET: INFORMATION OF THE USER

EXELON should only be used if prescribed to you by your doctor. EXELON contains the active substance rivastigmine hydrogen tartrate.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5%

PATIENT INFORMATION INCRUSE ELLIPTA

Guide for Patients & Caregivers

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. AZITHROMYCIN Azithromycin Tablets

CIALIS (See-AL-iss) (tadalafil) tablets

NicAssist 24 Hour Patch

Ask your doctor if you have any. has been prescribed for you. There is no evidence that LYCINATE is addictive or habit forming. Before you take it

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

PART III: PATIENT MEDICATION INFORMATION. CLINDAMYCINE-150 Pr. CLINDAMYCINE-300 (Clindamycin Hydrochloride Capsules USP) Clindamycin 150 mg and 300 mg

PART III: CONSUMER INFORMATION

PATIENT INFORMATION LEAFLET AMLOC RANGE

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. OMEPRAZOLE Omeprazole Delayed-Release Capsules

Patient Information. Telmisartan and Hydrochlorothiazide (TEL-mi-SAR-tan and HYE-droe-KLOR-oh-THYE-a-zide) Tablets. Rx Only

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. fentanyl transdermal system

LECTOPAM PRODUCT MONOGRAPH. bromazepam. 3 mg and 6 mg Tablets. Anxiolytic - Sedative. Date of Revision: September 6, 2018

IMPORTANT: PLEASE READ

Transcription:

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION TRANSDERM-NITRO nitroglycerin patch Read this carefully before you start taking TRANSDERM-NITRO and each time you get a refill. This leaflet is a summary and will not tell you everything about this drug. Talk to your healthcare professional about your medical condition and treatment and ask if there is any new information about TRANSDERM-NITRO Serious Warnings and Precautions Do NOT take any medication for the treatment of impotence (erectile dysfunction) such as VIAGRA* (sildenafil citrate), CIALIS* (tadalafil), LEVITRA* or STAXYN* (vardenafil) while using TRANSDERM-NITRO. Using TRANSDERM-NITRO together with medication for erectile dysfunction can result in life-threatening low blood pressure (hypotension) causing fainting, heart attack and death. What is TRANSDERM-NITRO used for? TRANSDERM-NITRO is used in adults to prevent angina (chest pain). It can be used alone or together with other antianginal agents such as beta-blockers and/or calcium channel blockers. TRANSDERM-NITRO is not intended to be used for acute angina attacks. Sublingual nitroglycerin medications should be used if you are having an acute angina attack. How does TRANSDERM-NITRO work? When TRANSDERM-NITRO is applied to the skin, it releases small amounts of nitroglycerin at a steady rate. This passes through the skin, into your bloodstream. It relaxes and widens the blood vessels and increases the supply of blood and oxygen to the heart. This helps prevent attacks of anginal pain (chest pain) from occurring. What are the ingredients in TRANSDERM-NITRO? Medicinal ingredients: Nitroglycerin Non-medicinal ingredients: colloidal silicon dioxide, lactose, and silicone medical fluid Patch layers contain aluminized plastic, ethylene/vinyl acetate copolymer and hypoallergenic silicone adhesive. TRANSDERM-NITRO comes in the following dosage forms: TRANSDERM-NITRO is available in three different patch strengths: TRANSDERM-NITRO 0.2 mg/hour (10 cm²) TRANSDERM-NITRO 0.4 mg/hour (20 cm 2 ) TRANSDERM-NITRO 0.6 mg/hour (30 cm 2 ) Page 1 of 9

Do not use TRANSDERM-NITRO if you: are allergic to nitroglycerin, nitrates, nitrites or any non-medicinal ingredient in the formulation. have had a recent heart attack, or other serious heart problems, stroke or head injury experience lightheadedness, dizziness or fainting when going from lying or sitting to standing up (postural hypotension). have narrowing of the heart valves. have a condition caused by an increase in normal brain pressure (increased intracranial pressure). have an eye disease called closed angle glaucoma or any other condition that increases the pressure in your eyes. have severe anemia (low iron levels in your blood or low red blood cell count). are taking medication for erectile dysfunction such as VIAGRA* (sildenafil citrate), CIALIS* (tadalafil), LEVITRA* or STAXYN* (vardenafil). are taking medications used to treat high blood pressure in your lungs such as ADEMPAS* (riociguat), REVATIO* (sildenafil citrate) or ADCIRCA* (tadalafil). To help avoid side effects and ensure proper use, talk to your healthcare professional before you take TRANSDERM-NITRO. Talk about any health conditions or problems you may have, including if you: have heart failure have low blood pressure or take diuretics ( water pills ) have lung disease are breast feeding, pregnant or intend to become pregnant. Your healthcare professional will decide whether you should use TRANSDERM-NITRO and what extra care should be taken during its use. are less than 18 years old or older than 65 years of age are dehydrated or suffer from excessive vomiting, diarrhea or sweating have angina due to hypertrophic cardiomyopathy Other warnings you should know about: Driving and using machines: Before you perform tasks which may require special attention, wait until you know how you respond to TRANSDERM-NITRO. Dizziness, lightheadedness, or fainting can occur, especially after the first dose and when the dose is increased. Tolerance to TRANSDERM-NITRO and similar drugs can occur after long periods of use. Chronic use can lead to angina attacks being brought on more easily. Do not suddenly stop using TRANSDERM-NITRO. Talk to your healthcare professional if you wish to discontinue using TRANSDERM-NITRO. TRANSDERM-NITRO is not for use in children. After normal use, there is enough residual nitroglycerin in discarded TRANSDERM-NITRO patches that they are a potential hazard to children and pets. Page 2 of 9

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines. Serious Drug Interactions If you are currently taking medications for the treatment of impotence (erectile dysfunction), such as sildenafil citrate, tadalafil or vardenafil or any other similar medication (PDE5 inhibitors), the use of TRANSDERM-NITRO may lead to extreme low blood pressure resulting in fainting, heart attack and death. If you are being treated with any of these drugs and need TRANSDERM-NITRO (e.g. in case of chest pain caused by an acute attack of angina) please seek emergency medical assistance immediately. The following may interact with TRANSDERM-NITRO : Do not take any drugs used to treat erectile dysfunction such as VIAGRA * (sildenafil citrate), CIALIS * (tadalafil), LEVITRA * or STAXYN * (vardenafil) if you are using TRANSDERM- NITRO. Drugs used to treat high blood pressure. such as: o Diuretics ( water pills ) o Calcium Channel Blockers (e.g. diltiazem, nifedipine, verapamil) o ACE Inhibitors o Beta-Blockers Drugs used to treat depression called tricyclic antidepressants. Tranquillizers. Other drugs that may have the same effect as TRANSDERM-NITRO. Alcohol Drugs used to treat migraine headaches (e.g. dihydroergotamine) Acetylsalicylic acid (Aspirin*) Nonsteroidal anti-inflammatory drugs (NSAIDs), used to reduce pain and swelling (such as ibuprofen, naproxen, and celecoxib). Do not use TRANSDERM-NITRO.if you are taking drugs used to treat high blood pressure in your lungs such as ADEMPAS * (riociguat), REVATIO * (sildenafil citrate) or ADCIRCA * (tadalafil). How to use TRANSDERM-NITRO : 1. Deciding Where to Apply the Patch Choose any area of skin which is most comfortable for you, but not past the knees or elbows. Many patients prefer the chest. It is best if the area is hairless. Avoid skin folds. The skin should not be scarred, burned, irritated or broken, since this may alter the amount of medicine you get. You should apply the patch to a different area of skin each day, and wait several days before using the same area again. To help you remember to change the site of patch application regularly, you may wish to use the same area of skin on a particular day of the week. Page 3 of 9

For example: Sunday 1 Monday 2 Tuesday 3 Wednesday 4 Thursday 5 Friday 6 Saturday 7 Figure 1 Sunday 1 Monday 2 etc. 2. Preparing the Skin In order for the patch to stick, the skin must be clean and dry without any creams, lotions, oil or powder. If hair is likely to interfere with the patch sticking or removal, it can be clipped but not shaved since this may irritate the skin. 3. Opening the Pouch Each TRANSDERM-NITRO patch is individually sealed in a protective pouch. Tear open this pouch at the indentation and remove the patch. Do not use scissors, since you may accidentally cut the patch. (Figure 2 & 3). TRANSDERM-NITRO is designed as a complete unit. Do not cut the patch. Page 4 of 9

Figure 2 Figure 3 4. Recognizing the Patch and Removing the Liner The patch itself is tan-coloured. A plastic liner covers the adhesive (sticky) side of the patch during storage, and must be removed and discarded before patch use. The plastic liner will be either white on both sides or clear, depending on the size of the patch. Pick up the patch lengthwise with the tab up, and the plastic liner facing you (Figure 4). If you are left-handed it might be easier to start with the tab down and the tan-coloured side facing you. Firmly bend the tab forward with the thumb. With both thumbs, carefully remove the plastic protective liner from the patch starting at the tab (Figure 5). Continue to peel back the plastic liner along the length of the patch, allowing the patch to rest on the outside of your fingers. (Figure 6) Figure 4 Figure 5 Figure 6 By removing the plastic liner you have exposed the adhesive side. The adhesive side of the patch appears to have a silver-coloured edge. From this side you should also be able to see the white cream containing nitroglycerin within the patch. Avoid touching the adhesive. If another person applies the patch for you, he/she must be careful not to touch the surface which will be applied to the skin. Apply the tan-coloured patch immediately after opening the pouch and removing the plastic liner. Discard the plastic liner. Page 5 of 9

5. Applying the Patch Remember, the skin should be clean and dry without creams, lotions, oil or powder. Place the exposed adhesive side of the patch (i.e. the silver-edged side) on the area you have chosen as explained above. Press it firmly in place with the palm of your hand for 10-20 seconds (Figure 7). Circle the outside edge of the patch with one or two fingers. Once the patch is in place, do not test the adhesion by pulling on it. When applied correctly, the tan-coloured side will be seen when looking at the patch on the skin. Figure 7 6. When and How to Remove the Patch The TRANSDERM-NITRO patch should be changed according to the schedule prescribed by your doctor. It is important to respect the patch-off period recommended by your doctor. If you forget to remove it at the scheduled time just remove it as soon as possible and continue to follow your original schedule. Remove the patch by pulling on the tab. Each patch can only be applied once. After use, fold the patch in half with the adhesive side inwards. Throw it away safely out of the reach of children. Any adhesive left on the skin can be removed with rubbing alcohol or light mineral oil. 7. What to Do if TRANSDERM-NITRO Falls Off Contact with water (as in bathing, swimming, showering) or physical activity will not affect the patch. It is unlikely that the patch will fall off. If the patch does fall off, discard it and put a new patch on a different area of skin. Continue to follow your original schedule. Usual adult dose: The daily dosage schedule is based on intermittent therapy (patch on period followed by a patchoff period) to prevent the development of tolerance to nitroglycerin. Page 6 of 9

Starting dose is one TRANSDERM-NITRO 0.2 mg/hour patch (10 cm²), usually applied in the morning. If 0.2 mg/hour (10 cm²) is well tolerated, the dose can be increased to 0.4 mg/hour (20 cm²) if required. A maximum of 0.8 mg/hour (40 cm²) may be used. Overdose: If you think you have used too much TRANSDERM-NITRO, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms. What are possible side effects from using TRANSDERM-NITRO? These are not all the possible side effects you may feel when taking TRANSDERM-NITRO. If you experience any side effects not listed here, contact your healthcare professional. Side effects may include: Headache Flushing of the face Nausea Vomiting Rash, redness, itching and/or burning in the area where the patch is applied. Page 7 of 9

Serious side effects and what to do about them Talk to your healthcare professional Symptom / effect Only if severe In all cases UNKNOWN Allergic Reaction: rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing. Unstable Angina: chest pain that has changed or gotten worse, nausea, anxiety, sweating, shortness of breath, dizziness, fatigue Increased levels of methemoglobin in the blood: shortness of breath, blue or purple coloration of the lips, fingers and/or toes, headache, fatigue, dizziness, loss of consciousness. Low Blood Pressure: dizziness, fainting, lightheadedness, fast heartbeat. May occur when you go from lying or sitting to standing up. High Blood Pressure: headache, vision problems, irregular heartbeat Stop taking drug and get immediate medical help If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional. Page 8 of 9

Reporting Side Effects You can help improve the safe use of health products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information. 3 ways to report: Online at MedEffect (www.healthcanada.gc.ca/medeffect); By calling 1-866-234-2345 (toll-free); By completing a Consumer Side Effect Reporting Form and sending it by: - Fax to 1-866-678-6789 (toll-free), or - Mail to: Canada Vigilance Program Health Canada, Postal Locator 0701E Ottawa, ON K1A 0K9 Postage paid labels and the Consumer Side Effect Reporting Form are available at MedEffect (www.healthcanada.gc.ca/medeffect). NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice. Storage: TRANSDERM-NITRO should be stored at temperatures below 25 C. Do not freeze. Do not store it out of the individually sealed pouch. TRANSDERM-NITRO should be kept out of the reach of children and pets both before use and when disposing of used patches. If your patch becomes stuck to a child or another person, remove the patch at once and contact a doctor. If you want more information about TRANSDERM-NITRO : Talk to your healthcare professional Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (http://www.hc-sc.gc.ca); the manufacturer s website http://www.novartis.ca or by calling 1-800-363-8883 This leaflet was prepared by Novartis Pharmaceuticals Canada Inc., 385 Bouchard, Dorval, Quebec, H9S 1A9. Last Revised: August 26, 2015 TRANSDERM-NITRO is a registered trademark. *All registered trademarks are the property of their respective owners. Page 9 of 9